{
    "title": "Pharmacogenetics association with long-term clinical evolution in a kidney transplant patients cohort",
    "pmid": "40761554",
    "pmcid": "PMC12319246",
    "study_parameters": [
        {
            "Study Parameters ID": 1454211336,
            "Variant Annotation ID": 1454211330,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "acute rejection during 12-year follow-up, recipient",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.047",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211330"
        },
        {
            "Study Parameters ID": 1454211353,
            "Variant Annotation ID": 1454211347,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "acute rejection during 12-year follow-up, donor",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.027",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211347"
        },
        {
            "Study Parameters ID": 1454211406,
            "Variant Annotation ID": 1454211400,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "nephrotoxicity during 12-year follow-up, donor",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.024",
            "Ratio Stat Type": "Unknown",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211400"
        },
        {
            "Study Parameters ID": 1454211266,
            "Variant Annotation ID": 1454211260,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "exitus during 12-year follow-up",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.029",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211260"
        },
        {
            "Study Parameters ID": 1454211277,
            "Variant Annotation ID": 1454211271,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "survival during 12-year follow-up",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.003",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211271"
        },
        {
            "Study Parameters ID": 1454211300,
            "Variant Annotation ID": 1454211280,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "survival during 12-year follow-up",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.138",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211280"
        },
        {
            "Study Parameters ID": 1454211346,
            "Variant Annotation ID": 1454211340,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "acute rejection during 12-year follow-up, recipient",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.024",
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211340"
        },
        {
            "Study Parameters ID": 1454211329,
            "Variant Annotation ID": 1454211323,
            "Study Type": null,
            "Study Cases": 79.0,
            "Study Controls": null,
            "Characteristics": "nephrotoxicity during 12-year follow-up",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.026",
            "Ratio Stat Type": "OR",
            "Ratio Stat": 11.652,
            "Confidence Interval Start": 1.509,
            "Confidence Interval Stop": 89.957,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1454211323"
        }
    ],
    "var_drug_ann": [],
    "var_pheno_ann": [
        {
            "Variant Annotation ID": 1454211330,
            "Variant/Haplotypes": "rs2740574",
            "Gene": "CYP3A4",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "Regarding acute rejection, statistical analysis showed that the CYP3A4 rs2740574 AA variant in the recipient could offer a protective effect (OR: 0.080; p-value: 0.047) compared to other variants at that location. \" Alleles complemented.",
            "Sentence": "Genotype TT is associated with decreased likelihood of Transplant rejection when treated with tacrolimus in people with Kidney Transplantation as compared to genotypes CC + CT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Transplant rejection",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC + CT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211330"
        },
        {
            "Variant Annotation ID": 1454211347,
            "Variant/Haplotypes": "rs3745274",
            "Gene": "CYP2B6",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "The presence of the TT variant in SLCO1B1 rs4149056 in the recipient and the GT variant in CYP2B6 rs3745274 in the donor were also statistically associated with a reduced risk (OR: 0.16 and 0.2, respectively) of acute rejection.",
            "Sentence": "Genotype GT is associated with decreased likelihood of Transplant rejection when treated with tacrolimus in people with Kidney Transplantation.",
            "Alleles": "GT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Transplant rejection",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211347"
        },
        {
            "Variant Annotation ID": 1454211400,
            "Variant/Haplotypes": "rs2306283",
            "Gene": "SLCO1B1",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "From Table 3. AA and AG genotype of Recipient and AG genotype of donor were association with lower odds of nephrotoxicity",
            "Sentence": "Genotypes AA + AG is associated with decreased likelihood of Nephrotoxicity when treated with tacrolimus in people with Kidney Transplantation.",
            "Alleles": "AA + AG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Nephrotoxicity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211400"
        },
        {
            "Variant Annotation ID": 1454211260,
            "Variant/Haplotypes": "rs9282564",
            "Gene": "ABCB1",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "The AA variant in the rs9282564 SNP of the donor's ABCB1 gene was significantly associated (p-value: 0.029) with a reduced risk (OR: 0.116) of exitus during the follow-up period.\" \"The AG variant in ABCB1 gene rs9282564 of the donor was significantly associated (p-value: 0.042; log-rank) with reduced cumulative survival compared to the AA variant (Fig. 1A).\" Alleles complemented.",
            "Sentence": "Genotype TT is associated with decreased risk of Death when treated with tacrolimus in people with Kidney Transplantation as compared to genotypes CC + CT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "risk of",
            "Phenotype": "Efficacy:Death",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC + CT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211260"
        },
        {
            "Variant Annotation ID": 1454211271,
            "Variant/Haplotypes": "rs2273697",
            "Gene": "ABCC2",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "patients receiving a graft from a donor with the GA genotype in rs2273697 of ABCC2 were significantly associated (p-value: 0.021) with an increased risk (OR: 4.133) of exitus.\" \" It was observed that the genotype in the donor's ABCC2 rs2273697 could significantly (p-value: 0.003; log-rank) affect survival (Fig. 1B), with the GG variant providing a higher rate during the entire follow-up compared to AA and GA.",
            "Sentence": "Genotype GG is associated with increased likelihood of overall survival when treated with tacrolimus in people with Kidney Transplantation as compared to genotypes AA + AG.",
            "Alleles": "GG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Overall survival",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "AA + AG",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211271"
        },
        {
            "Variant Annotation ID": 1454211280,
            "Variant/Haplotypes": "rs776746",
            "Gene": "CYP3A5",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "Although the CYP3A5 rs776746 did not show a significant association with survival in logistic regression, the Kaplan-Meier curve was also represented (Fig. 1C) due to its special relevance and clinical evidence on the response to tacrolimus. No significant difference was observed by log-rank either, but it should not be discarded that the GG variant (∗3/∗3) could offer an advantage, especially at late post-transplantation stages.\" Alleles complemented. No *1*1 shown on kaplan meier, graph marked as recipient",
            "Sentence": "Genotype CC is associated with increased likelihood of overall survival when treated with tacrolimus in people with Kidney Transplantation as compared to genotype CT.",
            "Alleles": "CC",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Overall survival",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211280"
        },
        {
            "Variant Annotation ID": 1454211340,
            "Variant/Haplotypes": "rs4149056",
            "Gene": "SLCO1B1",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Efficacy",
            "Significance": "yes",
            "Notes": "The presence of the TT variant in SLCO1B1 rs4149056 in the recipient and the GT variant in CYP2B6 rs3745274 in the donor were also statistically associated with a reduced risk (OR: 0.16 and 0.2, respectively) of acute rejection.\" \"Recipients with the TT variant in SLCO1B1 rs4149056 showed higher dose-adjusted tacrolimus concentrations, possibly mediating a greater immunosuppressive effect and protecting against rejection, consistent with our logistic regression results (OR: 0.157). ",
            "Sentence": "Genotype TT is associated with decreased likelihood of Transplant rejection when treated with tacrolimus in people with Kidney Transplantation.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Efficacy:Transplant rejection",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211340"
        },
        {
            "Variant Annotation ID": 1454211323,
            "Variant/Haplotypes": "rs4244285",
            "Gene": "CYP2C19",
            "Drug(s)": "tacrolimus",
            "PMID": 40761554,
            "Phenotype Category": "Toxicity",
            "Significance": "yes",
            "Notes": "An increased risk of nephrotoxicity was observed in patients receiving grafts carrying the AA variant in CYP2C19 rs4244285.",
            "Sentence": "Genotype AA is associated with increased likelihood of Nephrotoxicity when treated with tacrolimus in people with Kidney Transplantation.",
            "Alleles": "AA",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Nephrotoxicity",
            "Multiple phenotypes And/or": null,
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Other:Kidney Transplantation",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": null,
            "Comparison Metabolizer types": null,
            "PMID_norm": "40761554",
            "Variant Annotation ID_norm": "1454211323"
        }
    ],
    "var_fa_ann": []
}